This is a study by CAMH, the leading mental health research hospital in Canada. Learn more about what's involved in participating in a study at CAMH Research Connect.
Late-life depression (LLD) is one of the most common mental health issues facing older adults, with prevalence rates ranging from 1% to 5%. Its occurrence increases the risk of adverse health outcomes in particular, a higher risk of cognitive impairment, including Alzheimer's disease (AD).
Why LLD leads to memory and thinking problems and dementia is not fully understood. Current research at CAMH is trying to understand why this happens by using blood samples to measure different blood proteins. We hope that this information will give us better ways to treat depression and memory and thinking problems older adults in the future.
We are looking for participants who:
- Are 60-85 years of age
- Are currently experiencing symptoms of depression (e.g., feeling persistent sadness, lack of interest, feelings of worthlessness and/or guilt, fatigue, sluggishness or having trouble concentrating)
- Are willing to partake in a 2-year program with follow-up visits every 6 months
Participation in this study will last up to 24 months and will take place at our downtown Toronto location. The study will involve screening assessments, blood work, and cognitive assessments (to assess your memory, attention and cognitive abilities), and a one-time brain MRI.
To learn more or ask about joining our study, call us at 416-538-1350 or email SenDepStudy@camh.ca
You can also find our study details in our CAMH study listing.
CAMH REB # 127/2018